PP_1170x120_10-25-21

Linda Rendle promoted to Clorox CEO; Dorer to continue as board chair

Print Friendly, PDF & Email

OAKLAND, Calif. — The board of directors of The Clorox Co. announced earlier this week that effective, Sept. 14, Linda Rendle, a 17-year veteran of the company, will be promoted to chief executive officer and elected to the company’s board of directors. Benno Dorer will continue serving as the board’s executive chair.

Linda Rendle

Dorer has served as chief executive officer of the company since November 2014 and was appointed chair of the board in August 2016. As chair and CEO, he has had overall responsibility for leading the company’s worldwide business, which generated revenues of $6.7 billion in fiscal year 2020. Rendle is currently president of the company and prior to that was executive vice president – Cleaning, International, Strategy and Operations, among other leadership roles she has held at Clorox.

“I’m delighted that our dedication to thoughtful, long-term succession planning positioned us to appoint such a strong and capable leader as Linda Rendle to the CEO role. Linda will be an excellent CEO, building on her track record of outstanding business results, her strong oversight of the development of the company’s IGNITE strategy and her values-led leadership,” said Pamela Thomas-Graham, lead independent director of the board. “Benno has done a tremendous job leading the company through its 2020 Strategy with significant advancements in innovation, superior consumer value, digital consumer engagement, company culture and ESG. During this time, the company has more than doubled total shareholder return while delivering good growth – growth that is profitable, sustainable and responsible. The company is operating effectively during this pandemic, and I’m pleased that Benno will continue to provide strategic guidance as executive chair while he turns toward personal philanthropic activities.”

“I’m proud of what we have accomplished as a team for our shareholders and all stakeholders, including our employees, consumers and communities. With a healthy business, so much opportunity for continued good growth and a successor who is ready to lead this company, it’s the right time for the board to appoint Linda as CEO,” Dorer said. “Linda has an outstanding track record of achieving results, deep business and functional experience and is the architect of our IGNITE strategy. Clorox has a significant, ongoing opportunity to continue helping protect the health and wellness of our communities, and we are confident this is an appropriate time to transition to a CEO with a long runway and the skills to deliver on the opportunity ahead. Clorox will be in good hands as I pursue my passion for philanthropy in support of youth, sustainability and art.”

 


ECRM-08-202222

Adheris Health

Comments are closed.

Adheris Health